Mitral Valve Disease
The study is a multi-center, prospective, single-arm, and non-randomized study designed to evaluate the safety and function of the Edwards Lifesciences Cardi-AQ-Edwards™ Transcatheter Mitral Valve with the Transseptal Delivery System.
Principal Investigator: Robert L. Smith, II, MD
Locations: Baylor Scott & White The Heart Hospital – Plano
Sponsor: Edwards Lifesciences
IRB Number: 014-278
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating may change your care
Brittany Zingler, RN469.814.4737Brittany.Zingler@BSWHealth.org
Necole Kell, RN469.814.4871Necole.Kell@BSWHealth.org
Early Feasibility Study of the CardiAQ™ Transcatheter Mitral Valve Implantation (TMVI) System For Treatment of Moderate to Severe Mitral Regurgitation
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.